Key result
The number of tampon-associated toxic shock syndrome cases in Minnesota did not significantly differ during the 9 months Rely tampons were on the market (55 cases) versus the 9 months after (59 cases).
Observational (n=197)
Answers are grounded in this paper and cite their sources.
Active surveillance in Minnesota showed a stable incidence of toxic shock syndrome over 18 months, unaffected by the withdrawal of Rely tampons from the market.
In January 1980, the Minnesota Department of Health began the surveillance of toxic shock syndrome with epidemiologically defined active and passive components. The intensity of surveillance has been constant since its inception. As of 30 June 1981, 197 confirmed cases of toxic shock syndrome, 15% of all cases nationwide, have been identified in Minnesota. During the 18 months of active surveillance, the total cases reported per calendar quarter ranged from 20 to 24 cases, and the number of tampon-associated cases ranged from 15 to 21. There was no difference in the quarterly distribution of total (p greater than 0.2) or tampon-associated (p greater than 0.2) cases of toxic shock syndrome during the six quarters. Fifty-five tampon-associated cases had onset of illness during the 9 months of surveillance in which Rely tampons (Proctor & Gamble) were on the market; 59 tampon-associated cases had onset of illness during the 9 months after Rely tampons were removed from the market.
No takes yet. Share an insight, caveat, or question.
Osterholm et al. (1982) conducted an observational in Toxic shock syndrome (n=197). Rely tampons on the market vs. Rely tampons removed from the market was evaluated on Quarterly distribution of tampon-associated cases (p=>0.2). The number of tampon-associated toxic shock syndrome cases in Minnesota did not significantly differ during the 9 months Rely tampons were on the market (55 cases) versus the 9 months after (59 cases).
Synapse has enriched 10 related papers. Consider them for comparative context: